Duplicate LLOQ and ULOQ [Bioanalytics]

posted by Ohlbe – France, 2012-01-20 15:26 (4881 d 05:45 ago) – Posting: # 7982
Views: 5,014

Dear Helmut,

❝ ❝ What most people do is that they only use one of the two replicates of the LLOQ and ULOQ samples. Usually the first replicate is used,…


❝ Really most people?


In my experience, yes. I mean, most people analysing only the first and last samples in duplicate.

❝ That’s strange to me. Why the first and not the second? Why not both?


Their rationale is only to avoid having to truncate the curve if the first or last samples fail. If there is no objective reason to use the second value, they use the first to avoid nasty discussions with regulators (such as: the run passes with the second injection but fails with the first, why did you choose the second ? Did the first one fail by accident, or did the second one pass by chance ?).

Using both repetitions would make sense to improve the fit (the two ends of the curve are where you have the more uncertainty). But then you get into other discussions such as: if you consider you need duplicate analysis to get a correct fit, then you should also analyse the subject samples in duplicate...

Some other labs analyse the whole curve in duplicate, once at the start of the run and once at the end, to compensate for possible drifts. Personally if there is a drift I would rather shorten the run... But I think that's a discussion we had previously on the forum.

Regards
Ohlbe

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,677 registered users;
39 visitors (0 registered, 39 guests [including 28 identified bots]).
Forum time: 22:12 CEST (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5